(IOVA) |
| 0 (0%) 01-14 13:26 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.99 |
| Resistance 1: | 2.64 |
| Pivot price: | 2.62 |
| Support 1: | 2.08 |
| Support 2: | 1.73 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.190 |
| Book Value | 1.820 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.131 |
| Profit Margin (%) | -158.78 |
| Operating Margin (%) | -133.06 |
| Return on Assets (ttm) | -27.1 |
| Return on Equity (ttm) | -53.9 |
Company news
Mon, 12 Jan 2026
The Bull Case For Iovance Biotherapeutics (IOVA) Could Change Following Reaffirmed 2025 Guidance And TIL Scale-Up - simplywall.st
Mon, 12 Jan 2026
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Sat, 10 Jan 2026
Assessing Iovance Biotherapeutics (IOVA) Valuation After Revenue Guidance And 1,000 Patient Milestone - simplywall.st
Fri, 09 Jan 2026
Iovance Biotherapeutics, Inc. Updates Corporate Presentation - TradingView — Track All Markets
Fri, 09 Jan 2026
Iovance Biotherapeutics (IOVA) Stock Analysis: A Potential 219% Upside in the Biotech Arena - DirectorsTalk Interviews
Mon, 05 Jan 2026
Wells Fargo Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $14 - 富途牛牛
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
